Rimifon and Abdominal pain upper - a phase IV clinical study of FDA data

Summary:

Abdominal pain upper is reported as a side effect among people who take Rimifon (isoniazid), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Ethambutol Hydrochloride, and have Pulmonary tuberculosis.

The phase IV clinical study analyzes which people have Abdominal pain upper when taking Rimifon. It is created by eHealthMe based on reports of 925 people who have side effects when taking Rimifon from the FDA, and is updated regularly.

What is Rimifon?

Rimifon has active ingredients of isoniazid. eHealthMe is studying from 925 Rimifon users. Check the latest studies of Rimifon.

What is Abdominal pain upper?

Abdominal pain upper is found to be associated with 2,974 drugs and 4,486 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.

On Jul, 15, 2026

925 people reported to have side effects when taking Rimifon.
Among them, 14 people (1.51%) have Abdominal pain upper.

Could Rimifon cause Abdominal pain upper?

Among these 14 people:

How long have people been on Rimifon when they have Abdominal pain upper? *

What is the gender of people who have Abdominal pain upper when taking Rimifon? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Abdominal pain upper when taking Rimifon? *

What are other drugs people take besides Rimifon? *

Zyvox: 8 people, 57.14%
Ethambutol Hydrochloride: 8 people, 57.14%
Rifadin: 4 people, 28.57%
Myambutol: 4 people, 28.57%
Moxifloxacin Hydrochloride: 3 people, 21.43%
Prilosec: 2 people, 14.29%
Rifinah: 1 person, 7.14%
Xanax: 1 person, 7.14%
Bactrim: 1 person, 7.14%
Capreomycin Sulfate: 1 person, 7.14%

What are other side effects people have besides Abdominal pain upper? *

Nausea And Vomiting: 10 people, 71.43%
Pericarditis Tuberculous (tuberculosis infection of the pericardial membrane (pericardium) covering the heart): 8 people, 57.14%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 8 people, 57.14%
Visual Acuity Reduced (reduced clearness of vision): 8 people, 57.14%
Lactic Acidosis (low ph in body tissues): 8 people, 57.14%
Hepatic Failure (liver failure): 8 people, 57.14%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 57.14%
Abdominal Pain: 6 people, 42.86%
Deafness Neurosensory: 6 people, 42.86%
Pericardial Effusion (fluid around the heart): 6 people, 42.86%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 9 people, 64.29%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 7.14%
Hiv Infection: 1 person, 7.14%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 1 person, 7.14%
Disseminated Tuberculosis: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Rimifon and have Abdominal pain upper?

- Check whether Abdominal pain upper is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rimifon:

Rimifon (925 reports)

Browse all side effects of Rimifon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain upper:

Abdominal pain upper (2,974 drugs)

Browse all the conditions that are associated with Abdominal pain upper:

Abdominal pain upper (4,486 conditions)

Related publications that referenced our studies

Ganguly, R. J., Abraham, R. R., Prasad, R., & Rao, B. C, "Hyperglycaemia induced by isoniazid preventive therapy", Journal of Family Medicine and Primary Care, 2018 Jan .
Ganguly, R. J., Abraham, R. R., Prasad, R., & Rao, B. C, "Hyperglycaemia induced by isoniazid preventive therapy", Journal of Family Medicine and Primary Care, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on isoniazid (the active ingredients of Rimifon) and Rimifon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.